Literature DB >> 8233537

Ketamine hydrochloride in the treatment of phantom limb pain.

Catherine F Stannard1, Gwenda E Porter.   

Abstract

Three cases are described in which phantom limb pain was successfully treated with ketamine hydrochloride. Possible mechanisms for this observation are suggested.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8233537     DOI： 10.1016/0304-3959(93)90214-A

Source DB:  PubMed          Journal:  Pain        ISSN： 0304-3959            Impact factor:   6.961


  13 in total

1.  Phantom limb pain exacerbated by intravenous ketamine.

Authors:  Tetsuya Sakai; Koji Sumikawa
Journal:  J Anesth       Date:  2013-12-01       Impact factor: 2.078

Review 2.  Management strategies for chronic pain.

Authors:  D M Justins
Journal:  Ann Rheum Dis       Date:  1996-09       Impact factor: 19.103

Review 3.  Optimal treatment of phantom limb pain in the elderly.

Authors:  R Baron; G Wasner; V Lindner
Journal:  Drugs Aging       Date:  1998-05       Impact factor: 3.923

4.  Beneficial effect of ketamine hydrochloride in phantom limb pain: report of a case.

Authors:  Isao Tsuneyoshi; Yuichi Kanmura; Tatewaki Hidaka; Nozomu Yoshimura
Journal:  J Anesth       Date:  1997-12       Impact factor: 2.078

Review 5.  Glutamate receptors and nociception: implications for the drug treatment of pain.

Authors:  M E Fundytus
Journal:  CNS Drugs       Date:  2001-01       Impact factor: 5.749

6.  Potentiation of μ-opioid receptor-mediated signaling by ketamine.

Authors:  Achla Gupta; Lakshmi A Devi; Ivone Gomes
Journal:  J Neurochem       Date:  2011-09-20       Impact factor: 5.372

Review 7.  How do drugs relieve neurogenic pain?

Authors:  R Karlsten; T Gordh
Journal:  Drugs Aging       Date:  1997-11       Impact factor: 3.923

8.  Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain.

Authors:  Thomas Forst; Terry Smith; Klemens Schütte; Paul Marcus; Andreas Pfützner
Journal:  Br J Clin Pharmacol       Date:  2007-03-28       Impact factor: 4.335

9.  Effects of a partial agonist and a full antagonist acting at the glycine site of the NMDA receptor on inflammation-induced mechanical hyperalgesia in rats.

Authors:  J M Laird; G S Mason; J Webb; R G Hill; R J Hargreaves
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

10.  Effect of ketamine combined with magnesium sulfate in neuropathic pain patients (KETAPAIN): study protocol for a randomized controlled trial.

Authors:  Noémie Delage; Véronique Morel; Pascale Picard; Fabienne Marcaillou; Bruno Pereira; Gisèle Pickering
Journal:  Trials       Date:  2017-11-03       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.